| Literature DB >> 31763622 |
Alison H Chang1, Jungwha Lee2, Jing Song3, Lori Lyn Price4,5, Augustine C Lee5, Kieran F Reid6, Roger A Fielding6, Jeffrey B Driban5, William C Harvey5, Chenchen Wang5.
Abstract
OBJECTIVE: Examine whether pre-intervention physical activity (PA) level is associated with achieving a positive treatment response of pain and/or function improvement after a 12-week exercise intervention in participants with knee osteoarthritis (OA).Entities:
Keywords: Exercise; OMERACT; Osteoarthritis; Physical Activity
Year: 2019 PMID: 31763622 PMCID: PMC6857980 DOI: 10.1002/acr2.1013
Source DB: PubMed Journal: ACR Open Rheumatol ISSN: 2578-5745
Figure 1Outcome Measures in Rheumatoid Arthritis Clinical Trials‐Osteoarthritis Research Society International (OMERACT‐OARSI) responder criteria for defining clinically meaningful improvement at the end of exercise intervention (12 weeks).
Baseline characteristics of the analysis sample
| Entire Sample n = 166 | Responders n = 138 | Nonresponders n = 28 | |
|---|---|---|---|
| Number (%) or mean ± SD | |||
| Age (years) | 60.7 ± 10.5 | 61.3 ± 10.7 | 57.6 ± 9.0 |
| BMI (kg/m2) | 32.4 ± 6.9 | 32.1 ± 6.7 | 34.2 ± 7.8 |
| Female | 119 (71.7%) | 102 (73.9%) | 17 (60.7%) |
| K/L grade of the worse knee (n = 164, 136 responders) | |||
| 0 | 3 (1.8%) | 3 (2.2%) | 0 (0%) |
| 1 | 8 (4.9%) | 6 (4.4%) | 2 (7.1%) |
| 2 | 66 (40.2%) | 55 (40.4%) | 11 (39.3%) |
| 3 | 57 (34.8%) | 47 (34.6%) | 10 (35.7%) |
| 4 | 30 (18.3%) | 25 (18.4%) | 5 (17.9%) |
| WOMAC Pain (0‐500), higher indicates worse pain | 253.3 ± 100.7 | 253.0 ± 96.4 | 254.9 ± 121.4 |
| WOMAC Physical Function (0‐1700), higher indicates worse function | 885.4 ± 367.3 | 888.5 ± 362.8 | 870.3 ± 395.4 |
| Chronic Pain Self‐Efficacy (1‐10), higher indicates better status | 6.3 ± 2.1 | 6.5 ± 2.0 | 5.3 ± 2.3 |
| Beck Depression Inventory‐II (0‐63), higher indicates worse symptoms | 7.7 ± 8.6 | 7.1 ± 8.3 | 10.6 ± 9.6 |
| CHAMPS – Total activities (hr/wk) | 17.5 ± 12.2 | 17.6 ± 11.6 | 16.9 ± 14.8 |
| CHAMPS – MV intensity activities (hr/wk) | 5.5 ± 6.0 | 5.7 ± 5.9 | 4.8 ± 6.6 |
Abbreviation: BMI, body mass index; CHAMPS = Community Health Activities Model Program for Seniors; K/L = Kellgren/Lawrence; MV = moderate‐to‐vigorous; WOMAC = Western Ontario and McMaster Universities Arthritis Index.
Knees had definite osteophytes (K/L grade 2) in the patellofemoral compartment, but K/L grades 0 or 1 in the tibiofemoral compartment.
Pre‐intervention baseline self‐reported physical activity level (by CHAMPS questionnaire) and treatment response to exercise therapy (by OMERACT‐OARSI responder criteria) (n = 166)
| Total Activities | MV Intensity Activities | |
|---|---|---|
| Median (IQR), hr/wk | ||
|
Responders (n = 138, 83%) | 16.0 (14.0) | 4.0 (9.0) |
|
Nonresponders (n = 28, 17%) | 13.0 (19.0) | 2.0 (6.5) |
|
| 0.21 | 0.30 |
| Associations of baseline physical activity (per 1 hr/wk) with responders (reference group: nonresponders) | Odds ratios | |
| Unadjusted | 1.01 (0.97, 1.04), | 1.03 (0.96, 1.11), |
| Adjusted for age, sex, and BMI | 1.00 (0.96, 1.03), | 1.01 (0.93, 1.09), |
Abbreviations: CHAMPS, Community Health Activities Model Program for Seniors; CI, confidence interval; IQR, interquartile range; MV, moderate‐to‐vigorous; OMERACT‐OARSI, Clinical Trials Response Criteria and the Outcome Measures in Rheumatology – Osteoarthritis Research Society International.
Two‐sample Wilcoxon rank sum test comparing responders with nonresponders.
Odds ratio with 95% CI excluding 1 indicates statistical significance.
Baseline characteristics of the accelerometry subgroup
| Entire Sample n = 42 | Responders n = 37 | Nonresponders n = 5 | |
|---|---|---|---|
| Number (%) or median ± IQR | |||
| Age (years) | 60.5 ± 15.0 | 61.0 ± 9.0 | 55.0 ± 18.0 |
| BMI (kg/m2) | 30.1 ± 11.1 | 30.0 ± 11.1 | 30.3 ± 2.4 |
| Female | 30 (71.4%) | 28 (75.7%) | 2 (40%) |
| K/L grade of the worse knee | |||
| 0 | 1 (2.4%) | 1 (2.7%) | 0 |
| 1 | 2 (4.8%) | 2 (5.4%) | 0 |
| 2 | 19 (45.2%) | 17 (46.0%) | 2 (40.0%) |
| 3 | 11 (26.2%) | 10 (27.0%) | 1 (20.0%) |
| 4 | 9 (21.4%) | 7 (18.9%) | 2 (40.0%) |
| WOMAC Pain (0‐500), higher indicates worse pain | 243.1 ± 141.4 | 246.0 ± 138.3 | 240.1 ± 128.6 |
| WOMAC Physical Function (0‐1700), higher indicates worse function | 880.8 ± 607.5 | 843.0 ± 592.5 | 1069.3 ± 741.2 |
| Chronic Pain Self‐Efficacy (1‐10), higher indicates better status | 6.8 ± 3.9 | 7.1 ± 3.5 | 4.1 ± 2.8 |
| Beck Depression Inventory‐II (0‐63), higher indicates worse symptoms (n = 40) | 6.0 ± 10.5 | 5.0 ± 9.0 | 13.0 ± 9.0 |
| CHAMPS – Total activities (hr/wk) | 13.5 ± 13.0 | 13.0 ± 12.0 | 18.0 ± 17.0 |
| CHAMPS – MV intensity activities (hr/wk) | 3.5 ± 7.0 | 4.0 ± 5.0 | 0.0 ± 3.0 |
| Accelerometry – Total activities (hr/wk) | 41.3 ± 15.0 | 41.8 ± 12.1 | 32.6 ± 21.5 |
| Accelerometry – MV intensity activities (hr/wk) | 3.8 ± 5.1 | 3.9 ± 5.2 | 2.2 ± 0.6 |
| Accelerometry – Light intensity activities (hr/wk) | 36.5 ± 13.6 | 36.5 ± 9.9 | 30.4 ± 20.8 |
Abbreviation: BMI, body mass index; CHAMPS = Community Health Activities Model Program for Seniors; IQR = interquartile range; K/L = Kellen/Lawrence; MV = moderate‐to‐vigorous; WOMAC = Western Ontario and McMaster Universities Arthritis Index.
Knees had definite osteophytes (K/L grade 2) in the patellofemoral compartment, but K/L grades 0 or 1 in the tibiofemoral compartment.
Pre‐intervention baseline objectively measured physical activity level (by accelerometry) and treatment response to exercise therapy (by OMERACT‐OARSI responder criteria) (n = 42)
| Total Activities (Light + MV Intensity) | Light‐Intensity Activities | MV‐Intensity Activities | |
|---|---|---|---|
| Median (IQR), hr/wk | |||
|
Responders (n = 37, 86%) | 41.8 (12.1) | 36.5 (9.9) | 3.9 (5.2) |
|
Nonresponders (n = 5, 14%) | 32.6 (21.5) | 30.4 (20.8) | 2.2 (0.6) |
|
| 0.32 | 0.36 | 0.27 |
Abbreviation: IQR, interquartile range; MV, moderate‐to‐vigorous; OMERACT‐OARSI, Clinical Trials Response Criteria and the Outcome Measures in Rheumatology – Osteoarthritis Research Society International.
Two‐sample Wilcoxon rank sum test comparing responders with nonresponders.